Trazodone controlled-release

Drug Profile

Trazodone controlled-release

Alternative Names: AF-1161; DDS-04A; Extended release trazodone - Labopharm; Oleptro; Trazodone Contramid OAD (TCOAD) - Labopharm; Trazodone HCl - Labopharm; Trazodone OAD; Triticum AC; Trittico

Latest Information Update: 08 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Angelini Group; Labopharm
  • Developer Altus Formulation Inc; Angelini Group; Lees Pharmaceutical Holdings
  • Class Antidepressants; Erectile dysfunction therapies; Piperazines; Pyridones; Small molecules
  • Mechanism of Action Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Major depressive disorder
  • Phase II Diabetic neuropathies; Insomnia

Most Recent Events

  • 23 Feb 2017 Phase-II clinical trials in Diabetic neuropathies in Hungary (PO) (EudraCT2016-002772-27)
  • 27 May 2016 Lee's Pharmaceutical plans two phase I pharmacokinetics trials in Healthy volunteers in China (PO) (NCT02785614; NCT02785601)
  • 10 Sep 2015 Phase-II clinical trials in Insomnia in Italy (PO) before September 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top